2015 Original PMAs And Panel-Track Supplements
This article was originally published in The Gray Sheet
A sortable and searchable table of FDA original PMAs and panel-track supplements approved in 2015, updated monthly. Latest update: Approvals through October 31.
You may also be interested in...
Novartis’s cancer drug has now been filed for multiple sclerosis in the US, armed with a priority review, and in Europe.
Aetion is also working with the US Food and Drug Administration and a number of biopharma companies on projects involving use of real-world evidence.
Increased fines and penalties are on the cards for manufacturing facilities that fail to comply with proposed new requirements.